EcoDrugPlus

Ribosomal Protein S8

Ensembl ID : ENSBMUG00000016794
Gene Symbol: RPS8
3 Cross references
203 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSBMUG00000007072
Gene Symbol: RPS9
1 Cross references
199 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSBMUG00000021009
Gene Symbol: RPLP0
3 Cross references
177 Possible Orthologues:

Selectin E

Ensembl ID : ENSBMUG00000020899
Gene Symbol: SELE
3 Cross references
236 Possible Orthologues:

Selectin L

Ensembl ID : ENSBMUG00000020892
Gene Symbol: SELL
3 Cross references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSBMUG00000020869
Gene Symbol: SELP
3 Cross references
119 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSBMUG00000004958
Gene Symbol: SERPINC1
3 Cross references
200 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSBMUG00000018090
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSBMUG00000023048
Gene Symbol: SIRT1
3 Cross references
159 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSBMUG00000023453
Gene Symbol: SMO
3 Cross references
203 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSBMUG00000006521
Gene Symbol: SCNN1A
3 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSBMUG00000024565
Gene Symbol: SCNN1B
3 Cross references
151 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).